搜索
Kymera Therapeutics Inc
KYMR添加自选
116.330USD
+3.180+2.81%
收盘 09-16 16:00（美东）
9.64B总市值
亏损市盈率 TTM
Kymera Therapeutics Inc
116.330
+3.180+2.81%
KYMR 现金流量表
您可以访问Kymera Therapeutics Inc的年度和季度现金流量表，以评估其财务稳健性和稳定性。
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2019Q4
经营活动现金流量（间接法）
持续经营活动现金净额
9.72%-54.06M
-12.24%-88.84M
-8.03%-66.75M
45.99%-27.11M
-39.47%-59.88M
-99.92%-79.15M
-867.98%-61.78M
-58.59%-50.19M
-21.78%-42.94M
9.95%-39.59M
120.35%8.04M
7.65%-31.65M
9.57%-35.26M
-9.12%-43.97M
-3.09%-39.54M
8.03%-34.27M
-27.77%-38.98M
-76.55%-40.30M
-91.11%-38.35M
-128.30%-37.26M
---30.51M
---22.82M
-85.80%-20.07M
--131.67M
---10.80M
持续经营净收入
20.10%-61.21M
-5.57%-69.23M
-22.94%-86.98M
-31.51%-82.17M
-82.15%-76.61M
-35.06%-65.58M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.80M
-11.57%-40.93M
-2.85%-34.87M
-50.45%-43.00M
-63.25%-40.26M
-180.57%-36.68M
-167.24%-33.90M
-257.86%-28.58M
---24.66M
---13.07M
-10.18%-12.69M
---7.99M
---11.51M
持续经营损益
-2.59%2.03M
-1.27%2.02M
2.32%2.03M
202.16%6.00M
7.53%2.08M
-67.93%2.05M
123.01%1.99M
122.01%1.99M
115.33%1.94M
626.51%6.39M
8.92%891.00K
16.69%895.00K
27.66%900.00K
27.95%879.00K
18.72%818.00K
14.31%767.00K
27.72%705.00K
41.65%687.00K
38.63%689.00K
36.94%671.00K
--552.00K
--485.00K
37.67%497.00K
--490.00K
--361.00K
其他非现金项目
-9.71%-2.33M
-8.12%-2.73M
37.40%-2.04M
39.61%-2.19M
47.25%-2.12M
17.81%-2.52M
-157.45%-3.27M
-197.70%-3.62M
-183.77%-4.02M
-131.67%-3.07M
-40.22%-1.27M
-1998.28%-1.22M
-309.31%-1.42M
-212.85%-1.33M
-155.32%-905.00K
-103.49%-58.00K
-45.05%677.00K
-8.13%1.18M
4.14%1.64M
1409.09%1.66M
--1.23M
--1.28M
1315.32%1.57M
--110.00K
--111.00K
营运资金变化
-950.85%-11.49M
-27.74%-34.91M
263.14%5.79M
3750.57%35.45M
110.29%1.35M
-332.63%-27.32M
-129.86%-3.55M
-109.82%-971.00K
-84.44%-13.13M
47.27%-6.32M
188.14%11.89M
1039.83%9.89M
26.84%-7.12M
10.25%-11.98M
12.69%-13.49M
94.29%-1.05M
27.16%-9.73M
9.11%-13.35M
-37.04%-15.46M
-113.47%-18.42M
---13.36M
---14.68M
-19685.96%-11.28M
--136.73M
---57.00K
-应收款项（增）减
0.00%-20.00M
100.00%0.00
-100.00%0.00
10262.69%40.00M
-6216.21%-20.00M
-213.87%-19.05M
102.47%370.00K
12.21%386.00K
140.77%327.00K
2236.91%16.73M
-4430.92%-14.98M
167.06%344.00K
27.49%-802.00K
30.59%-783.00K
-75.94%346.00K
23.32%-513.00K
-233.25%-1.11M
-274.75%-1.13M
267.99%1.44M
-15.94%-669.00K
--830.00K
---301.00K
---856.00K
---577.00K
--0.00
-预付费用（增）减
104.39%223.00K
-228.42%-3.56M
89.77%-322.00K
107.23%266.00K
-646.93%-5.08M
192.38%2.78M
-230.29%-3.15M
-857.81%-3.68M
139.48%929.00K
-83.12%-3.00M
603.54%2.42M
66.37%-384.00K
-293.50%-2.35M
-180.03%-1.64M
83.72%-480.00K
-16.89%-1.14M
67.72%1.22M
28.19%-586.00K
-24.07%-2.95M
-231.67%-977.00K
--725.00K
---816.00K
-1220.00%-2.38M
--742.00K
---180.00K
-其他流动资产变化
216.16%2.37M
-8.62%615.00K
-30.80%-1.69M
-157.11%-1.45M
-338.97%-2.04M
8.72%673.00K
-144.26%-1.29M
245.63%2.53M
-7.09%852.00K
-45.61%619.00K
439.81%2.92M
450.38%732.00K
627.78%917.00K
856.30%1.14M
54.26%-859.00K
23.15%133.00K
23.53%126.00K
25.26%119.00K
-2335.71%-1.88M
-88.99%108.00K
--102.00K
--95.00K
-90.20%84.00K
--981.00K
--857.00K
-其他流动负债变化
-107.41%-2.16M
-1052.90%-32.21M
55.79%-3.04M
-26.94%-2.47M
218.40%29.11M
64.98%-2.79M
-166.63%-6.87M
-233.16%-1.95M
-95.51%-24.59M
-37.88%-7.98M
179.27%10.31M
91.44%-585.00K
-27.49%-12.58M
25.89%-5.79M
10.99%-13.01M
62.96%-6.84M
46.74%-9.86M
55.83%-7.81M
-24.66%-14.61M
-113.57%-18.46M
---18.52M
---17.68M
-548.04%-11.72M
--136.04M
---1.81M
非持续经营活动现金净额
经营活动现金净额
9.72%-54.06M
-12.24%-88.84M
-8.03%-66.75M
45.99%-27.11M
-39.47%-59.88M
-99.92%-79.15M
-867.98%-61.78M
-58.59%-50.19M
-21.78%-42.94M
9.95%-39.59M
120.35%8.04M
7.65%-31.65M
9.57%-35.26M
-9.12%-43.97M
-3.09%-39.54M
8.03%-34.27M
-27.77%-38.98M
-76.55%-40.30M
-91.11%-38.35M
-128.30%-37.26M
---30.51M
---22.82M
-85.80%-20.07M
--131.67M
---10.80M
投资活动现金流量
持续投资活动现金净额
-31.94%473.00K
-7.07%434.00K
-88.68%106.00K
195.77%181.00K
-85.18%695.00K
-93.69%467.00K
-91.95%936.00K
-102.34%-189.00K
-56.45%4.69M
84.63%7.40M
3016.62%11.63M
548.31%8.08M
1365.03%10.77M
731.74%4.01M
-25.55%373.00K
307.19%1.25M
17.41%735.00K
193.90%482.00K
-65.14%501.00K
-87.30%306.00K
--626.00K
--164.00K
622.11%1.44M
--2.41M
--199.00K
资本性支出
-31.94%473.00K
-7.07%434.00K
-88.68%106.00K
--181.00K
-85.18%695.00K
-93.69%467.00K
-91.95%936.00K
----
-56.45%4.69M
84.63%7.40M
3016.62%11.63M
548.31%8.08M
1365.03%10.77M
731.74%4.01M
-25.55%373.00K
307.19%1.25M
17.41%735.00K
193.90%482.00K
-65.14%501.00K
-87.30%306.00K
--626.00K
--164.00K
622.11%1.44M
--2.41M
--199.00K
固定资产交易的净现金流
-31.94%473.00K
-7.07%434.00K
-88.68%106.00K
195.77%181.00K
-85.18%695.00K
-93.69%467.00K
-91.95%936.00K
-102.34%-189.00K
-56.45%4.69M
84.63%7.40M
3016.62%11.63M
548.31%8.08M
1365.03%10.77M
731.74%4.01M
-25.55%373.00K
307.19%1.25M
17.41%735.00K
193.90%482.00K
-65.14%501.00K
-87.30%306.00K
--626.00K
--164.00K
622.11%1.44M
--2.41M
--199.00K
投资产品交易的净现金流
-66.21%20.52M
-390.14%-142.41M
-667.29%-394.29M
-48.93%-235.12M
198.64%60.72M
115.19%49.08M
127.31%69.50M
-330.17%-157.87M
-56.38%20.33M
-1230.36%-323.20M
162.03%30.58M
289.29%68.59M
-43.53%46.61M
8.53%28.59M
26.99%-49.29M
73.47%-36.23M
34.54%82.54M
-40.78%26.34M
-2544.65%-67.52M
58.86%-136.56M
--61.35M
--44.49M
-104.11%-2.55M
---331.91M
--62.16M
其他投资活动的净现金流
--0.00
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
非持续投资活动现金净额
投资活动现金净额
-66.60%20.05M
-393.82%-142.84M
-675.19%-394.40M
-49.23%-235.30M
283.72%60.02M
114.70%48.62M
261.80%68.57M
-360.58%-157.68M
-56.35%15.64M
-1444.81%-330.61M
138.16%18.95M
261.44%60.51M
-56.19%35.84M
-4.95%24.58M
26.98%-49.67M
72.61%-37.48M
34.72%81.80M
-41.65%25.86M
-1604.74%-68.02M
59.06%-136.86M
--60.72M
--44.32M
-106.44%-3.99M
---334.32M
--61.96M
融资活动现金流量
持续融资活动现金净额
-94.13%14.42M
7174.81%18.77M
25405.21%705.22M
-84.25%39.51M
17302.69%245.73M
-99.93%258.00K
42.97%2.77M
121904.85%250.92M
8.20%1.41M
30422.52%353.76M
-0.97%1.93M
-100.14%-206.00K
258.52%1.30M
526.49%1.16M
-4.92%1.95M
-38.83%150.50M
-77.14%364.00K
-68.91%185.00K
660.74%2.05M
25.35%246.04M
--1.59M
--595.00K
-98.72%270.00K
--196.28M
--21.09M
债务发行/偿还的净现金流
-14.14%-436.00K
-53.43%-425.00K
-41.98%-416.00K
34.63%-419.00K
-8.52%-382.00K
4.48%-277.00K
-131.68%-293.00K
-88.53%-641.00K
-5.39%-352.00K
11.31%-290.00K
403.28%925.00K
-16.44%-340.00K
-24.16%-334.00K
-23.86%-327.00K
-95.51%-305.00K
17.05%-292.00K
-44.62%-269.00K
-70.32%-264.00K
-2.63%-156.00K
-222.94%-352.00K
---186.00K
---155.00K
-28.81%-152.00K
---109.00K
---118.00K
普通股发行/偿还的净现金流
----
----
--656.23M
-85.65%35.38M
--237.29M
-100.00%0.00
--0.00
--246.51M
--0.00
--350.11M
--0.00
----
----
----
--0.00
-37.78%149.82M
----
----
-100.00%0.00
31.76%240.79M
----
----
--398.00K
--182.75M
----
优先股发行/偿还的净现金流
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--21.18M
职工行使股票期权收到的现金
68.54%14.86M
3487.66%19.19M
1515.60%49.41M
-9.91%4.55M
399.66%8.81M
-86.40%535.00K
203.07%3.06M
3670.90%5.05M
7.63%1.76M
164.67%3.93M
-55.31%1.01M
-86.10%134.00K
158.93%1.64M
230.96%1.49M
0.85%2.26M
-70.39%964.00K
-64.40%633.00K
-60.85%449.00K
9229.17%2.24M
2887.16%3.26M
--1.78M
--1.15M
-14.29%24.00K
--109.00K
--28.00K
其他融资活动的净现金流额
--1.47M
----
--656.23M
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
-100.00%0.00
--0.00
100.00%0.00
---29.00K
-82.65%2.35M
--0.00
---397.00K
--0.00
--13.53M
----
非持续融资活动现金净额
融资活动现金净额
-94.13%14.42M
7174.81%18.77M
25405.21%705.22M
-84.25%39.51M
17302.69%245.73M
-99.93%258.00K
42.97%2.77M
121904.85%250.92M
8.20%1.41M
30422.52%353.76M
-0.97%1.93M
-100.14%-206.00K
258.52%1.30M
526.49%1.16M
-4.92%1.95M
-38.83%150.50M
-77.14%364.00K
-68.91%185.00K
660.74%2.05M
25.35%246.04M
--1.59M
--595.00K
-98.72%270.00K
--196.28M
--21.09M
现金净流量
期初现金流
56.52%149.90M
187.83%362.81M
1.92%118.74M
365.11%341.64M
-3.59%95.77M
8.87%126.05M
34.15%116.50M
26.24%73.45M
76.44%99.33M
55.36%115.78M
-46.32%86.85M
-29.92%58.19M
41.30%56.30M
37.77%74.52M
2.12%161.77M
-4.01%83.03M
-27.14%39.84M
65.96%54.09M
180.96%158.41M
37.81%86.49M
--54.69M
--32.59M
918.08%56.38M
--62.76M
--5.54M
当期现金流变化
-107.97%-19.60M
-603.21%-212.91M
2456.02%244.07M
-617.79%-222.90M
1049.94%245.86M
-84.14%-30.28M
-66.99%9.55M
50.21%43.05M
-1470.87%-25.88M
9.78%-16.44M
133.16%28.93M
-63.61%28.66M
-95.63%1.89M
-27.92%-18.23M
16.36%-87.25M
9.50%78.75M
35.78%43.18M
-164.48%-14.25M
-338.53%-104.32M
1227.40%71.92M
--31.80M
--22.09M
-132.92%-23.79M
---6.38M
--72.25M
期末现金流
-61.86%130.30M
56.52%149.90M
187.83%362.81M
1.92%118.74M
365.11%341.64M
-3.59%95.77M
8.87%126.05M
34.15%116.50M
26.24%73.45M
76.44%99.33M
55.35%115.78M
-46.32%86.84M
-29.92%58.19M
41.30%56.30M
37.77%74.53M
2.12%161.77M
-4.01%83.03M
-27.14%39.84M
65.96%54.09M
180.96%158.41M
--86.49M
--54.69M
-58.10%32.59M
--56.38M
--77.79M
自由现金流
9.97%-54.54M
-12.13%-89.27M
-6.59%-66.85M
45.62%-27.29M
-27.20%-60.58M
-69.42%-79.62M
-1651.96%-62.72M
-26.34%-50.19M
-3.48%-47.63M
2.05%-46.99M
91.03%-3.58M
-11.85%-39.73M
-15.87%-46.02M
-17.66%-47.98M
-2.72%-39.91M
5.46%-35.52M
-27.57%-39.72M
-77.39%-40.78M
-80.67%-38.85M
-129.06%-37.57M
---31.14M
---22.99M
-95.50%-21.50M
--129.26M
---11.00M
货币单位
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
审计意见
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
常见问题
什么是经营活动现金流？
经营活动现金流是公司核心业务产生或使用的现金。它以净利润为基础，并对折旧等非现金项目以及应收账款、存货和应付账款等营运资金变动进行调整。强劲的经营活动现金流通常表明，公司能够将销售收入和利润有效转化为实际现金。
Kymera Therapeutics Inc 产生了多少经营活动现金流？
Kymera Therapeutics Inc 2025 财年的经营活动现金流为 -232.89M，反映其核心业务经营活动产生的现金。
Kymera Therapeutics Inc 的经营活动现金流同比有何变化？
Kymera Therapeutics Inc 的经营活动现金流同比增长 -19.74%。
什么是投资活动现金流？
投资活动现金流反映公司投资相关活动所使用或产生的现金，例如资本支出、投资买卖、企业收购和资产处置。投资活动现金流为负并不一定是坏事，因为这可能意味着公司正在为未来增长进行投入。不过，投资者仍需判断这些投资能否带来长期回报。
Kymera Therapeutics Inc 的资本支出是多少？
Kymera Therapeutics Inc 最近一个季度的资本支出为 1.45M。
什么是融资活动现金流？
融资活动现金流反映公司如何筹集资金，或向投资者和债权人返还资金，包括发行和偿还债务、发行和回购股份、支付股息以及租赁融资等。融资活动现金流为正，可能表示公司筹集了新资金；为负则可能反映公司正在偿还债务、派发股息或回购股份。
Kymera Therapeutics Inc 的融资活动现金流有何变化？
Kymera Therapeutics Inc 最近一个季度用于融资活动的现金为 990.71M。
什么是自由现金流？它对 KYMR 有何重要意义？
自由现金流是公司在支付维持或拓展业务所需的资本支出后剩余的现金。它通常用于评估公司的财务灵活性、偿债能力、股息可持续性、股份回购能力和估值水平。投资者还应将自由现金流与净利润、营收增长和资本支出结合分析。
Kymera Therapeutics Inc 最近一个季度的自由现金流是多少？
Kymera Therapeutics Inc 最近一个季度的自由现金流为 -234.34M，较上年同期变动 -13.02%。